Greystone Medical Group and UTHSC have been awarded $1 million from the U.S. Department of Defense to research and develop hemostatic agents for treating battlefield injuries.
The newly established Neuropathy Research Foundation and UTHSC announced a long-term commitment to fund research and establish a lab devoted to studying peripheral neuropathy.
UT professor, James B. Dale, MD, is involved in a clinical research study that is making headway in developing a vaccine against a common strep germ. Results of the study co-authored by Dr. Dale are reported in the August 11 issue of JAMA.
UTHSC is pleased to announce that Mohammad Jahanzeb, MD, has been named interim director of the UT Cancer Institute, and Lawrence Pfeffer, PhD, has been named interim deputy director.
UTHSC associate professor, John E. Delzell, Jr., MD,has been awarded a $269,433 grant from the U.S. Department of Health and Human Services Health Resources and Services Administration.
Research to Prevent Blindness (RPB) has awarded a $110,000 grant to the UTHSC Department of Ophthalmology to support research into the causes, treatment and prevention of blinding diseases.
With a scheduled completion date of summer 2008, plans are moving forward for a new building to house the University of Tennessee College of Pharmacy.
Several ophthalmologists have joined the Hamilton Eye Institute at the University of Tennessee. As faculty, they will also be practicing at the UT Medical Group offices on Wolf River Parkway in Germantown.